Last updated: 21 July 2019 at 11:23pm EST

Gregory Marvell Net Worth




The estimated Net Worth of Gregory Marvell is at least $4.65 Milione dollars as of 4 February 2011. Gregory Marvell owns over 40,078 units of Brooks Automation stock worth over $4,157,556 and over the last 15 years Gregory sold BRKS stock worth over $491,757.

Gregory Marvell BRKS stock SEC Form 4 insiders trading

Gregory has made over 1 trades of the Brooks Automation stock since 2011, according to the Form 4 filled with the SEC. Most recently Gregory sold 40,078 units of BRKS stock worth $491,757 on 4 February 2011.

The largest trade Gregory's ever made was selling 40,078 units of Brooks Automation stock on 4 February 2011 worth over $491,757. On average, Gregory trades about 8,016 units every 0 days since 2010. As of 4 February 2011 Gregory still owns at least 36,760 units of Brooks Automation stock.

You can see the complete history of Gregory Marvell stock trades at the bottom of the page.



What's Gregory Marvell's mailing address?

Gregory's mailing address filed with the SEC is C/O BROOKS AUTOMATION, INC., 15 ELIZABETH DRIVE, CHELMSFORD, MA, 08124.

Insiders trading at Brooks Automation

Over the last 21 years, insiders at Brooks Automation have traded over $110,337,278 worth of Brooks Automation stock and bought 84,885 units worth $755,883 . The most active insiders traders include Stephen S Schwartz, Amin J Khoury e A Clinton Allen. On average, Brooks Automation executives and independent directors trade stock every 22 days with the average trade being worth of $1,392,261. The most recent stock trade was executed by David Jarzynka on 19 November 2021, trading 10,216 units of BRKS stock currently worth $1,228,883.



What does Brooks Automation do?

Brooks Automation Inc. is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europeand Asia.



Complete history of Gregory Marvell stock trades at Brooks Automation

Persona
Trans.
Transazione
Prezzo totale
Gregory Marvell
Vicepresidente e Extended Factory Group
Vendita $491,757
4 Feb 2011


Brooks Automation executives and stock owners

Brooks Automation executives and other stock owners filed with the SEC include: